PL3829563T3 - Kwas 3-sulfopropanowy do leczenia zaburzeń neurodegeneracyjnych - Google Patents
Kwas 3-sulfopropanowy do leczenia zaburzeń neurodegeneracyjnychInfo
- Publication number
- PL3829563T3 PL3829563T3 PL19752795.5T PL19752795T PL3829563T3 PL 3829563 T3 PL3829563 T3 PL 3829563T3 PL 19752795 T PL19752795 T PL 19752795T PL 3829563 T3 PL3829563 T3 PL 3829563T3
- Authority
- PL
- Poland
- Prior art keywords
- neurodegenerative disorders
- treating neurodegenerative
- sulfopropanoic acid
- sulfopropanoic
- acid
- Prior art date
Links
- OURSFPZPOXNNKX-UHFFFAOYSA-N 3-sulfopropanoic acid Chemical compound OC(=O)CCS(O)(=O)=O OURSFPZPOXNNKX-UHFFFAOYSA-N 0.000 title 1
- 208000015122 neurodegenerative disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862713061P | 2018-08-01 | 2018-08-01 | |
| PCT/US2019/044023 WO2020028290A1 (en) | 2018-08-01 | 2019-07-30 | Methods for treating neurodegenerative disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3829563T3 true PL3829563T3 (pl) | 2025-04-07 |
Family
ID=67614642
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19752795.5T PL3829563T3 (pl) | 2018-08-01 | 2019-07-30 | Kwas 3-sulfopropanowy do leczenia zaburzeń neurodegeneracyjnych |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US12083082B2 (pl) |
| EP (1) | EP3829563B1 (pl) |
| JP (1) | JP7573512B2 (pl) |
| KR (1) | KR102716959B1 (pl) |
| CN (1) | CN112867485A (pl) |
| AU (1) | AU2019315853B2 (pl) |
| BR (1) | BR112021001739A2 (pl) |
| CL (1) | CL2021000269A1 (pl) |
| DK (1) | DK3829563T3 (pl) |
| EA (1) | EA202190406A1 (pl) |
| ES (1) | ES3011716T3 (pl) |
| FI (1) | FI3829563T3 (pl) |
| HR (1) | HRP20250206T1 (pl) |
| HU (1) | HUE070101T2 (pl) |
| IL (1) | IL280424B2 (pl) |
| LT (1) | LT3829563T (pl) |
| MX (1) | MX2021001287A (pl) |
| MY (1) | MY206530A (pl) |
| PH (1) | PH12021550213A1 (pl) |
| PL (1) | PL3829563T3 (pl) |
| PT (1) | PT3829563T (pl) |
| RS (1) | RS66516B1 (pl) |
| SG (1) | SG11202100767XA (pl) |
| SI (1) | SI3829563T1 (pl) |
| SM (1) | SMT202500080T1 (pl) |
| UA (1) | UA130011C2 (pl) |
| WO (1) | WO2020028290A1 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3983563A1 (en) * | 2019-06-17 | 2022-04-20 | Alzheon, Inc. | Methods for treating neurodegenerative disorders |
| JP2024542844A (ja) * | 2021-12-09 | 2024-11-15 | アルツェオン・インコーポレーテッド | アルツハイマー病の処置に使用されるａｌｚ－８０１ |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5840294A (en) * | 1993-03-29 | 1998-11-24 | Queen's University At Kingston | Method for treating amyloidosis |
| CN101600730B (zh) * | 2006-10-12 | 2014-01-29 | Bhi有限合资公司 | 递送3-氨基-1-丙磺酸的方法、化合物、组合物和载体 |
| EP2852388A4 (en) | 2012-05-23 | 2016-01-13 | Univ Johns Hopkins | COMPOUNDS AND METHOD FOR USE THEREOF FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES |
| WO2014121083A1 (en) * | 2013-01-31 | 2014-08-07 | President And Fellows Of Harvard College | Methods of increasing neuronal connectivity and/or treating a neurodegenerative condition |
| KR102448386B1 (ko) * | 2014-03-21 | 2022-09-28 | 알제온, 인크. | 신경학적 장애를 치료하는 방법 |
| SMT202300250T1 (it) * | 2015-09-10 | 2023-09-06 | Alzheon Inc | Trattamento della malattia di alzheimer in una particolare popolazione di pazienti |
-
2019
- 2019-07-30 EP EP19752795.5A patent/EP3829563B1/en active Active
- 2019-07-30 CN CN201980064415.6A patent/CN112867485A/zh active Pending
- 2019-07-30 SM SM20250080T patent/SMT202500080T1/it unknown
- 2019-07-30 IL IL280424A patent/IL280424B2/en unknown
- 2019-07-30 US US17/264,477 patent/US12083082B2/en active Active
- 2019-07-30 HU HUE19752795A patent/HUE070101T2/hu unknown
- 2019-07-30 DK DK19752795.5T patent/DK3829563T3/da active
- 2019-07-30 AU AU2019315853A patent/AU2019315853B2/en active Active
- 2019-07-30 BR BR112021001739-9A patent/BR112021001739A2/pt unknown
- 2019-07-30 JP JP2021505721A patent/JP7573512B2/ja active Active
- 2019-07-30 PT PT197527955T patent/PT3829563T/pt unknown
- 2019-07-30 HR HRP20250206TT patent/HRP20250206T1/hr unknown
- 2019-07-30 FI FIEP19752795.5T patent/FI3829563T3/fi active
- 2019-07-30 EA EA202190406A patent/EA202190406A1/ru unknown
- 2019-07-30 LT LTEPPCT/US2019/044023T patent/LT3829563T/lt unknown
- 2019-07-30 ES ES19752795T patent/ES3011716T3/es active Active
- 2019-07-30 PL PL19752795.5T patent/PL3829563T3/pl unknown
- 2019-07-30 MX MX2021001287A patent/MX2021001287A/es unknown
- 2019-07-30 MY MYPI2021000515A patent/MY206530A/en unknown
- 2019-07-30 SG SG11202100767XA patent/SG11202100767XA/en unknown
- 2019-07-30 SI SI201930898T patent/SI3829563T1/sl unknown
- 2019-07-30 RS RS20250164A patent/RS66516B1/sr unknown
- 2019-07-30 UA UAA202101015A patent/UA130011C2/uk unknown
- 2019-07-30 WO PCT/US2019/044023 patent/WO2020028290A1/en not_active Ceased
- 2019-07-30 KR KR1020217005803A patent/KR102716959B1/ko active Active
-
2021
- 2021-01-28 PH PH12021550213A patent/PH12021550213A1/en unknown
- 2021-02-01 CL CL2021000269A patent/CL2021000269A1/es unknown
-
2024
- 2024-08-02 US US18/793,452 patent/US20250213507A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL279308A (en) | Methods for the treatment of heptidine-mediated disorders | |
| IL256380A (en) | Vesicular monoamine transporter 2 inhibitors for the treatment of neurological diseases or disorders | |
| IL262222A (en) | Anti-aging antibodies for the treatment of neurodegenerative disorders | |
| SMT201900172T1 (it) | Ammino triazoli sostituiti utili come inibitori della chitinasi umana | |
| IL281052A (en) | Treatment of liver disorders | |
| IL273705A (en) | Benzothiazole compounds and methods of using them for the treatment of neurodegenerative diseases | |
| HUE056356T2 (hu) | Tetrahidro-8H-pirido[1,2-a]pirazin-8-on vegyületek, mint COMT inhibitorok neurodegeneratív rendellenességek kezelésére | |
| IL253914A0 (en) | 1-Heterocyclyl isochromanyl compounds and analogs for the treatment of cns disorders | |
| ZA201800831B (en) | Compositions and methods for treating and preventing neurodegenerative disorders | |
| GB201803010D0 (en) | Neurodegenerative disorders | |
| ZA201907238B (en) | Compositions for treating neurodegenerative diseases | |
| SG11202007286TA (en) | Methods for treating mitochondrial disorders | |
| DK3829568T3 (en) | Sulfopropanoic acid derivatives for treating neurodegenerative disorders | |
| EP3313387A4 (en) | METHOD AND COMPOSITION FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES | |
| DK3829563T3 (en) | 3-sulfopropanoic acid for treating neurodegenerative disorders | |
| GB201701404D0 (en) | Therapies for treating inflammatory disorders | |
| GB201701455D0 (en) | Neurodegenerative disorders | |
| IL289018A (en) | Methods for treating neurodegenerative disorders | |
| HK40105684B (en) | Sulfopropanoic acid derivatives for treating neurodegenerative disorders | |
| HK40072836A (en) | Methods for treating neurodegenerative disorders | |
| HK40069546A (en) | Methods for treating neurodegenerative disorders | |
| HK40019969A (en) | Methods for treating neurodegenerative disorders | |
| HK40017730A (en) | Methods for treating mitochondrial disorders | |
| PT3420084T (pt) | Nova abordagem para tratamento de disfunções inflamatórias |